4Accepted Oct 2, 4:24 PM ET
Bristol Myers Squibb Co: director Derica W Rice received 620.994 shares
Accepted (ET)
4:24 PM
Oct 2, 2026
Filed
Oct 2, 2026
Documents
1
Size
5.8 KB
Summary
Bristol Myers Squibb Co: director Derica W Rice received 620.994 shares
What happened
- Derica W Rice, a director, received 620.994 deferred share units (derivative award) on Sep 30, 2026, at $62.40 per share, with a reported value of $38,750. The transaction type is listed as A (award/grant or other acquisition).
Key details
- Transaction date and price: Sep 30, 2026; 620.994 units at $62.40 each.
- Amount acquired: 620.994 deferred share units; total reported value $38,750.
- Shares owned after the transaction: not reported in this Form 4.
- Relevant footnotes:
- F1: Each deferred share unit will be converted into a share of common stock upon settlement. The units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
- F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
- Filing date: filed on Oct 02, 2026.
Why it may matter
- This was a derivative award of deferred share units that will convert into common stock upon settlement as described in F1.
- The award is part of deferred compensation and dividend reinvestment arrangements per F2.
- A filing does not show why the insider traded or why the company acted.